Coherus Oncology (CHRS) Convertible Debt (2016 - 2025)
Coherus Oncology's Convertible Debt was $228.57 million in Q1 2025, up 0.6% from $227.22 million a year earlier and up 0.1% from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) Convertible Debt (2016 - 2025) Analysis & Trends
At the end of FY2024, Convertible Debt at Coherus Oncology came in at $228.23 million, up 0.6% from FY2023.
- Convertible Debt shows a five-year compound annual growth rate of 23.8% (FY2019 to FY2024).
- In earlier years, Convertible Debt was $226.89 million in FY2023 (+0.6%), $225.58 million in FY2022 (-32.2%), $332.77 million in FY2021 (+49.2%) and $223.03 million in FY2020 (+184.0%).
- The Q1 2025 figure marks the highest quarterly Convertible Debt since Q4 2021.
- Compared with a year earlier, Convertible Debt has increased for nine straight quarters, with growth averaging 0.6% over the last eight quarters.
- The best year-over-year quarter for Convertible Debt over five years was Q2 2020 (growth of 185.4%); the worst was Q4 2022 (a decline of 32.2%).
- Per Business Quant data, CHRS's Convertible Debt in the three quarters before Q1 2025 was $228.23 million (Q4 2024), $227.89 million (Q3 2024) and $227.56 million (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn |
| 10 | Coherus Oncology | 155.59 Mn | -480.55 Mn | 10.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 228.57 Mn |
| Dec 31, 2024 | 228.23 Mn |
| Sep 30, 2024 | 227.89 Mn |
| Jun 30, 2024 | 227.56 Mn |
| Mar 31, 2024 | 227.22 Mn |
| Dec 31, 2023 | 226.89 Mn |
| Sep 30, 2023 | 226.56 Mn |
| Jun 30, 2023 | 226.23 Mn |
| Mar 31, 2023 | 225.90 Mn |
| Dec 31, 2022 | 225.58 Mn |
| Sep 30, 2022 | 225.25 Mn |
| Jun 30, 2022 | 224.93 Mn |
| Mar 31, 2022 | 224.61 Mn |
| Dec 31, 2021 | 332.77 Mn |
| Sep 30, 2021 | 223.97 Mn |
| Jun 30, 2021 | 223.66 Mn |
| Mar 31, 2021 | 223.34 Mn |
| Dec 31, 2020 | 223.03 Mn |
| Sep 30, 2020 | 222.72 Mn |
| Jun 30, 2020 | 222.41 Mn |
API Access
Coherus Oncology Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();